News|Articles|July 28, 2026

Peli BioThermal, PAXAFE Partnership Signals AI-Powered Cold Chain Future

Listen

0:00 / 0:00

Key Takeaways

Pairing packaging hardware with AI software enables a unified offering spanning physical protection, live sensor telemetry, automated deviations workflows, and audit-ready reporting for GDP-aligned cold chain operations.
Peli’s Crēdo Vault, CrēdoGO, and DV10 shippers become instrumented assets when coupled with PAXAFE’s lane planning and predictive analytics to proactively manage delay and excursion risk.
Expanding across 90 countries with ISO 9001 and EcoVadis-linked sustainability positioning targets increasingly global distribution networks under tightening regulatory scrutiny.
Industry momentum is shifting from retrospective temperature logging to AI “control towers” that forecast disruption, trigger contingency routing, and preserve product integrity before failures occur.

Peli BioThermal and PAXAFE are partnering to pair cold chain packaging with AI-powered monitoring, signaling where pharma logistics technology is headed next.

Peli BioThermal and PAXAFE announced a strategic partnership July 28 that pairs cold chain packaging with AI-powered digital monitoring and predictive analytics.¹ The deal offers a window into where pharma cold chain is heading over the next several years, as physical packaging and real-time intelligence increasingly function as a single offering rather than separate tools.

How Does the Partnership Combine Packaging and Intelligence?

Under the partnership, Peli BioThermal's packaging portfolio, including the Crēdo Vault bulk shipper, CrēdoGO reusable shipper and DV10 dry vapor shipper, is paired with PAXAFE's intelligence platform for lane planning, real-time visibility, quality operations and predictive analytics. The companies describe the combination as covering the full spectrum of pharmaceutical supply chain needs, from physical protection in transit to intelligent analysis, alerting and compliance reporting.¹

Additionally, the partnership spans a combined footprint across 90 countries and covers joint competency in GDP, GMP and international frameworks including ISO 9001 and EcoVadis sustainability recognition.

Both Companies framed the deal against an industry backdrop of intensifying regulatory requirements and increasingly global, complex supply chains, pointing to shared customers and markets and an end-to-end monitoring lifecycle running from smart devices in the field to cloud-based dashboards and automated reporting as evidence their strengths are complementary.

"Peli BioThermal has built its reputation by being the partner life sciences companies can rely on when it matters most — protecting products at every stage of the cold chain," said Sam Herbert, CEO of Peli BioThermal, in a press release.¹ "Together, we give the pharmaceutical industry something it has always needed: proven cold chain packaging reliability combined with the power of cutting-edge digital intelligence in a single, fully integrated solution."

Doug Ross, president and chief operating officer at Peli BioThermal, said the partnership brings together "trusted packaging expertise and advanced digital intelligence to deliver a smarter, more connected future for pharmaceutical logistics."¹"What we are building together is not a vendor relationship — it is a shared commitment to raising the standard of what integrated pharmaceutical supply chain monitoring can deliver,” added PAXAFE CEO, Ilya Preston.

Where Is Cold Chain Technology Headed Next?

The partnership lands alongside a broader industry shift toward AI-powered control towers for cold chain, systems that ingest real-time sensor data across a distribution network and use machine learning to predict delays or temperature risk before they materialize rather than simply logging what already happened.² In practice, that could mean a control tower flagging a rerouted flight during a winter storm and automatically prompting planners to deploy backup containers or reassign doses from standby stock before a shipment is at risk.

In a recent interview with Pharmaceutical Commerce, Joydeep Ganguly, chief operations and quality officer at Agilent Technologies, noted operational efficiency, enhanced resilience and sustainability as areas in which 4IR tools like AI will be leveraged in the pharmaceutical cold chain. At the time, Ganguly noted that “the pharmaceutical supply chain is currently navigating a period of radical restructuring,” moving away from the "efficiency-at-all-costs" model that defined the last 20 years toward a paradigm of resilient, high-velocity intelligence.

The partnership follows Peli BioThermal’s 2025 acquisition of Evo, a cryogenic shipping and tracking brand, from BioLife Solutions to strengthen its cell and gene therapy logistics capabilities. Herbert described that move in similar terms at the time.

References

1. Peli BioThermal Partners with PAXAFE to Redefine Pharmaceutical Cold Chain Intelligence. PR Newswire. July 28, 2026. https://www.prnewswire.com/news-releases/peli-biothermal-partners-with-paxafe-to-redefine-pharmaceutical-cold-chain-intelligence-302836596.html

2. Pharma Cold Chain Software & GDP Compliance Guide 2026. IntuitionLabs. Updated June 20, 2026. https://intuitionlabs.ai/articles/pharma-cold-chain-software-gdp-compliance

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.